VYNE 8-K 2026-07-14

VYNE Therapeutics Inc. (VYNE) 8-K dated 2026-07-14 — accession 0001104659-26-083356. This URL is the filing, not the VYNE hub.

VYNE Therapeutics Inc. (VYNE) is a biotechnology company listed on NASDAQ.

VYNE Therapeutics Inc. filed a 8-K on 2026-07-14. Accession 0001104659-26-083356.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VYNE revenue for 2025-12-31 was $570.0K. Net income was -$26.5M. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. VYNE currently screens at market cap $21.1M.

Not investment advice. The VYNE SEC hub lists recent forms. The stock page is the research view.